• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Pharmacoeconomic analysis of mycophenolate mofetil versus azathioprine in primary cadaveric renal transplantation.

作者信息

Baker G M, Martin J E, Jang R, Schroeder T J, Armitstead J A, Myre S, First M R

机构信息

Department of Pharmacy, University of Cincinnati Medical Center, Ohio 45267-0740, USA.

出版信息

Transplant Proc. 1998 Dec;30(8):4082-4. doi: 10.1016/s0041-1345(98)01349-9.

DOI:10.1016/s0041-1345(98)01349-9
PMID:9865304
Abstract
摘要

相似文献

1
Pharmacoeconomic analysis of mycophenolate mofetil versus azathioprine in primary cadaveric renal transplantation.
Transplant Proc. 1998 Dec;30(8):4082-4. doi: 10.1016/s0041-1345(98)01349-9.
2
One-year, single-center cost analysis of mycophenolate mofetil versus azathioprine following cadaveric renal transplantation.
Transplant Proc. 1999 Feb-Mar;31(1-2):274-5. doi: 10.1016/s0041-1345(98)01624-8.
3
The cost effectiveness of mycophenolate mofetil in the first year after primary cadaveric transplant. U.S. Renal Transplant Mycophenolate Mofetil Study Group.霉酚酸酯在尸体供肾初次移植后第一年的成本效益。美国肾移植霉酚酸酯研究组。
J Am Soc Nephrol. 1997 Oct;8(10):1592-8. doi: 10.1681/ASN.V8101592.
4
Mycophenolate mofetil versus azathioprine in organ transplantation.
Am J Transplant. 2009 Dec;9(12):2856-7. doi: 10.1111/j.1600-6143.2009.02853.x. Epub 2009 Oct 21.
5
[Economic contribution of mofetil mycofenolate as preventive immunosuppressive treatment after renal transplantation from cadaver].
Presse Med. 1996 Nov 2;25(33):1577-82.
6
Postmarketing evaluation of mycophenolate mofetil-based triple therapy immunosuppression compared with a conventional azathioprine-based regimen reveals enhanced efficacy and early pharmacoeconomic benefit after renal transplantation.与传统的硫唑嘌呤方案相比，基于霉酚酸酯的三联免疫抑制疗法的上市后评估显示，肾移植后疗效增强且具有早期药物经济学效益。
Transplant Proc. 1998 Dec;30(8):4096-7. doi: 10.1016/s0041-1345(98)01355-4.
7
Improved outcome of steroid withdrawal in mycophenolate mofetil-treated primary cadaveric renal transplant recipients.
Transplant Proc. 1999 Feb-Mar;31(1-2):1131-2. doi: 10.1016/s0041-1345(98)01933-2.
8
Mycophenolate mofetil eliminates the rationale for antilymphocyte induction therapy in nonhaploidentical living-donor kidney transplants.霉酚酸酯消除了非单倍体活体供肾移植中抗淋巴细胞诱导治疗的理论依据。
Transplant Proc. 1997 Feb-Mar;29(1-2):342-3. doi: 10.1016/s0041-1345(96)00300-4.
9
Mofetil mycophenolate in renal transplantation.
Transplant Proc. 2001 Feb-Mar;33(1-2):1082-3. doi: 10.1016/s0041-1345(00)02425-8.
10
Reduction in the incidence of early rejection in cadaveric renal allograft recipients treated with ATGAM induction and sequential mycophenolate mofetil.
Transplant Proc. 1997 Feb-Mar;29(1-2):313-4. doi: 10.1016/s0041-1345(96)00280-1.

引用本文的文献

1
Mycophenolate mofetil: a pharmacoeconomic review of its use in solid organ transplantation.霉酚酸酯：对其在实体器官移植中应用的药物经济学综述
Pharmacoeconomics. 2002;20(10):675-713. doi: 10.2165/00019053-200220100-00004.